IMIM - Institut Hospital del Mar d'Investigacions Mèdiques IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Agenda

13/01/2022

Recent Advances in Genitourinary Malignancies (RAGM-2022) - 13 January 2022

Hybrid Congress - PRBB Auditorium - www.ragm.online (15:30h - 20:30h)

On 13 January 2022 will take place a new edition of "Recent Advances in Genitourinary Malignancies (RAGM-2022)" organized by IMIM, Genesis Care and Clínica Corachan and directed by Dr. Joaquim Bellmunt , Dr. Escarlata López and Dr. Juan Pablo Fusco from Genesis Care. Given the circumstances this time format will be hybrid.

For more information and registration please click https://www.ragm.online/

Registration is already open and it's free.

The program is as follows: 

15:30 - 16:00 Registration

16:00 - 16:10 Welcome and Opening
Dr. Joan Albanell

16:10 - 16:20 Welcome from Dr Wally Curran, GenesisCare Global CMO 


16:20 - 17:50 Round Table 1: Prostatic Cancer
Moderator: Escarlata López

16:20 - 16:25 Presentation

16:25 - 16:40 Precision medicine in prostatic cancer
Dr. Álvaro Martínez

16:40 - 16:55 Theragnostics in prostatic cancer
Dr. Nat Lenzo

16:55 - 17:10 New standard of care for patients with de novo mCSPC (PEACE1 trial)
Dr. Karim Fizazi

17:10 - 17:25 New era of radiotherapy treatments in radioncology (Spacers SBRT reirradiation)
Dr. Elena Moreno

17:25 - 17:40 Discussion

17:40 - 18:00 Coffee break

18:00 - 19:20 Round Table 2: Bladder Cancer
Moderator: Joaquim Bellmunt

18:00 - 18:05 Presentation

18:05 - 18:20 Maintenance immunotherapy in bladder cancer
Dr. Thomas Powles

18:20 - 18:35 Adjuvant therapy in MIBC
Dr. Begoña Pérez Valderrama

18:35 - 18:50 FGFr as a target for urothelial tumors
Dr. Yohann Loriot

18:50 - 19:05 Recent advanced in antibody drug conjugates
Dr. Jonathan Rosenberg

19:05 - 19:20 Discussion
 

19:20 - 20:20 Round Table 3: Kidney Cancer
Moderator: Juan Pablo Fusco

19:20 - 19:35 Adjuvant immunotherapy after nephrectomy in renal cell carcinoma
Dr. Alejo Rodríguez-Vida

19:35 - 19:50 New standard in first line of treatment in metastatic renal cell carcinoma patients
Dr. Javier Puente

19:50 - 20:05 SBRT for renal and adrenal lesions
Dr. Daniel Rivas

20:05 - 20:20 Discussion

20:20 - 20:30 Closing remarks
Dr. Joaquín Arribas

Download the program

______________________________________________________

Contact
Meeting Pharma, A/A Asun Torres
atorres@meetingpharma.com

More events

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact